B Cells in Health and Disease
- 31 March 2006
- journal article
- review article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 81 (3), 377-384
- https://doi.org/10.4065/81.3.377
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- B cell signalling as therapeutic targetAnnals Of The Rheumatic Diseases, 2004
- B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximabArthritis & Rheumatism, 2004
- Successful Therapy of Rheumatoid Arthritis With RituximabJCR: Journal of Clinical Rheumatology, 2004
- Treatment of IgM antibody associated polyneuropathies using rituximabJournal of Neurology, Neurosurgery & Psychiatry, 2003
- RituximabDrugs, 2003
- Anti-CD20-based therapy of B cell lymphoma: state of the artLeukemia, 2002
- Receptor Revision of Immunoglobulin Heavy Chain Variable Region Genes in Normal Human B LymphocytesThe Journal of Experimental Medicine, 2000
- Revising B Cell ReceptorsThe Journal of Experimental Medicine, 2000
- Analysis of Heavy and Light Chain Pairings Indicates that Receptor Editing Shapes the Human Antibody RepertoireJournal of Molecular Biology, 1999
- Receptor-Mediated Antigen Uptake and its Effect on Antigen Presentation to Class II-Restricted T LymphocytesAnnual Review of Immunology, 1990